These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33461594)

  • 41. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation.
    da Cunha IW; da Costa WH; Morini MA; Bezerra SM; Carraro DM; Torrezan GT; Formiga MNC; Guimaraes GC; Zequi SC; Soares FA
    Virchows Arch; 2018 Dec; 473(6):775-779. PubMed ID: 30171332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [From gene to disease; cutaneous leiomyomatosis].
    Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of three hereditary leiomyomatosis patients with cryotherapy.
    Uyar B; Acar EM; Subaşıoğlu A
    Dermatol Ther; 2020 Mar; 33(2):e13226. PubMed ID: 31917494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hereditary leiomyomatosis and renal cell cancer (HLRCC).
    Kiuru M; Launonen V
    Curr Mol Med; 2004 Dec; 4(8):869-75. PubMed ID: 15579034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
    Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
    Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature.
    Yu Y; Zheng M; Zhu W; Zhao F; Guan B; Shen Q; Yang F; He Q; Li X
    Urol Oncol; 2021 Nov; 39(11):791.e9-791.e16. PubMed ID: 34462205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
    Toro JR; Nickerson ML; Wei MH; Warren MB; Glenn GM; Turner ML; Stewart L; Duray P; Tourre O; Sharma N; Choyke P; Stratton P; Merino M; Walther MM; Linehan WM; Schmidt LS; Zbar B
    Am J Hum Genet; 2003 Jul; 73(1):95-106. PubMed ID: 12772087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients.
    Seo JY; Ahn JY; Keam B; Kim M; Yoon S; Lee JL; Park K; Park I
    Ann Lab Med; 2021 Mar; 41(2):207-213. PubMed ID: 33063682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma.
    Refae MA; Wong N; Patenaude F; Bégin LR; Foulkes WD
    Nat Clin Pract Oncol; 2007 Apr; 4(4):256-61. PubMed ID: 17392716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a rapid autopsy report of metastatic renal cell carcinoma.
    Udager AM; Alva A; Chen YB; Siddiqui J; Lagstein A; Tickoo SK; Reuter VE; Chinnaiyian AM; Mehra R
    Am J Surg Pathol; 2014 Apr; 38(4):567-77. PubMed ID: 24625422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC).
    Martínek P; Grossmann P; Hes O; Bouda J; Eret V; Frizzell N; Gill AJ; Ondič O
    Virchows Arch; 2015 Aug; 467(2):185-91. PubMed ID: 25985877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous Leiomyoma: A Clinical Study of 152 Patients.
    Marcoval J; Llobera-Ris C; Moreno-Vílchez C; Penín RM
    Dermatology; 2022; 238(3):587-593. PubMed ID: 34569484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fumarate Hydratase-Deficient Renal Cell Carcinoma.
    Gupta S; Erickson LA
    Mayo Clin Proc; 2020 Mar; 95(3):619-621. PubMed ID: 32138894
    [No Abstract]   [Full Text] [Related]  

  • 54. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma.
    Skala SL; Dhanasekaran SM; Mehra R
    Arch Pathol Lab Med; 2018 Oct; 142(10):1202-1215. PubMed ID: 30281371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conventional renal cancer in a patient with fumarate hydratase mutation.
    Lehtonen HJ; Blanco I; Piulats JM; Herva R; Launonen V; Aaltonen LA
    Hum Pathol; 2007 May; 38(5):793-6. PubMed ID: 17270241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR Spectroscopy for Detecting Fumarate Hydratase Deficiency in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
    Wu G; Liu G; Wang J; Pan S; Luo Y; Xu Y; Kong W; Sun P; Xu J; Xue W; Zhang J
    Radiology; 2022 Dec; 305(3):631-639. PubMed ID: 35943337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family.
    Arenas Valencia C; Rodríguez López ML; Cardona Barreto AY; Garavito Rodríguez E; Arteaga Díaz CE
    Fam Cancer; 2017 Jan; 16(1):117-122. PubMed ID: 27566483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma.
    Zhang L; Walsh MF; Jairam S; Mandelker D; Zhong Y; Kemel Y; Chen YB; Musheyev D; Zehir A; Jayakumaran G; Brzostowski E; Birsoy O; Yang C; Li Y; Somar J; DeLair D; Pradhan N; Berger MF; Cadoo K; Carlo MI; Robson ME; Stadler ZK; Iacobuzio-Donahue CA; Joseph V; Offit K
    Hum Mutat; 2020 Jan; 41(1):103-109. PubMed ID: 31444830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC).
    Thompson AJ; Alwan YM; Ramani VAC; Evans DG; Maher ER; Woodward ER
    J Med Genet; 2023 Jan; 60(1):41-47. PubMed ID: 35121648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Could fumarate hydratase germline mutation in cutaneous leiomyomas predict Hereditary Leiomyoma and Renal Cell Cancer (HLRCC)?
    You FR; Lai HJ; Yang L; Guo HW
    Asian J Surg; 2023 Dec; 46(12):5531-5532. PubMed ID: 37591757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.